Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11419425 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina;   Percutaneous Coronary Intervention
Interventions: Drug: Tirofiban (Aggrastat);   Drug: Placebo
2 Completed Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
Conditions: Coronary Disease;   Angina, Unstable
Interventions: Drug: Abciximab;   Drug: Placebo

Indicates status has not been verified in more than two years